Welcome to our dedicated page for Celanese Del SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Celanese Corporation (NYSE: CE) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including Form 8-K current reports and other documents filed with the U.S. Securities and Exchange Commission. Celanese is a global specialty materials and chemical company in the basic organic chemical manufacturing industry, and its filings offer detailed insight into its financing activities, governance developments and operational decisions.
Recent Form 8-K filings describe a range of material events. Several filings outline registered offerings of senior notes by Celanese US Holdings LLC, a wholly owned subsidiary, including 7.000% Senior Notes due 2031 and 7.375% Senior Notes due 2034. These filings explain that net proceeds are used to repay borrowings under a five-year term loan credit agreement due 2027, fund cash tender offers for outstanding senior notes due 2027 and 2028, and support general corporate purposes, which may include repayment of other indebtedness.
Other 8-K reports cover cash tender offers for the company’s 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, including announcements of the commencement of tender offers, early results and increases in the maximum tender amount and series cap. Additional filings detail a revolving credit agreement providing a five-year unsecured revolving credit facility and an amendment to an existing term loan credit agreement, including new covenant terms.
Celanese filings also document operational and portfolio actions, such as the intended closure of an acetate tow production facility in Lanaken, Belgium, with associated expected non-cash accelerated depreciation and other shutdown costs, and the signing of a purchase and sale agreement to divest the Micromax® portfolio of products. Governance-related filings include the resignation of a Board member and the company’s explanation that the departure was not due to any disagreement on operations, policies or practices.
On Stock Titan, these SEC filings are presented with real-time updates from EDGAR and AI-powered summaries that help explain the key points of each document. Users can quickly understand the implications of Celanese’s 8-K disclosures, senior note offerings, credit agreements, tender offers and other reported events without reading every technical detail.
Celanese Corporation reported solid 2025 cash-generation despite a weak demand backdrop. The company delivered full-year 2025 adjusted earnings per share of $3.98 and operating EBITDA of $1.9 billion. Free cash flow reached $773 million, more than 50 percent higher than 2024, driven by cost reductions, working capital releases and disciplined spending.
Engineered Materials produced 2025 adjusted EBIT of $720 million and operating EBITDA of $1.2 billion at margins of 13 percent and 22 percent. The Acetyl Chain generated adjusted EBIT of $695 million and operating EBITDA of $947 million, also at 16–22 percent margins. Fourth-quarter 2025 adjusted EPS was $0.67, with free cash flow of $160 million.
Celanese refinanced about $4 billion of debt, cutting 2026–2027 maturities from $4.8 billion to $2.1 billion, and closed the Micromax® divestiture for $492 million in cash. For 2026, the company targets free cash flow of $650–$750 million, $50–$70 million of additional cost savings, and first‑quarter adjusted EPS of $0.70–$0.85, while continuing to prioritize deleveraging.
Celanese Corporation reported a challenging 2025 with a large GAAP loss but solid cash generation. Full-year 2025 U.S. GAAP diluted loss per share was $10.44, while adjusted earnings per share were $3.98. Net sales were $9.5 billion, down 7% from the prior year, driven by lower prices and volumes in key end markets.
The company posted a 2025 operating loss of $786 million, but adjusted EBIT reached $1.15 billion and operating EBITDA was $1.89 billion. Free cash flow was $773 million, helped by cost reductions, lower capital spending, and inventory reductions. A $1.1 billion goodwill impairment in Engineered Materials was a major factor behind the GAAP loss.
In the fourth quarter, Celanese delivered U.S. GAAP diluted earnings per share of $0.23 and adjusted earnings per share of $0.67 on net sales of $2.2 billion, a sequential 9% decline as volumes softened. Management expects first-quarter 2026 adjusted earnings per share of $0.70 to $0.85 and targets 2026 free cash flow of $650 million to $750 million while continuing deleveraging and cost-saving initiatives.
Celanese Corp. (CE) received a Schedule 13G filing showing that Capital Research Global Investors beneficially owns 5,565,556 shares of Celanese common stock, representing 5.1% of the class as of December 31, 2025.
The filing states these shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Celanese. Capital Research Global Investors reports sole voting and sole dispositive power over all 5,565,556 shares out of 109,504,894 shares believed to be outstanding.
Celanese Corporation director Kathryn Hill reported a routine equity compensation transaction. On January 1, 2026, she converted 1,808.351 shares of phantom stock into 1,808.351 shares of Celanese common stock at a price of $0 per share under the company’s 2008 Deferred Compensation Plan.
After this conversion, she directly held 16,808.48 shares of common stock and 1,140.519 phantom stock units. Each phantom stock unit represents the right to receive one share of common stock, payable in shares as provided by the deferred compensation plan.
Celanese Corporation reported that Director Scott M. Sutton resigned from its Board of Directors effective January 4, 2026. He stepped down because of the expected responsibilities and time commitment required for his new role as Chief Executive Officer of Rayonier Advanced Materials Inc. The company states that his resignation is not due to any disagreement with Celanese regarding its operations, policies, or practices.
The Board acknowledges Mr. Sutton’s numerous contributions during his tenure and extends well wishes for his new position. Celanese also issued a press release on January 6, 2026, to publicly announce his resignation.
Celanese Corporation reports that its wholly owned subsidiary Celanese US Holdings LLC has completed a registered debt offering of $600,000,000 of 7.000% Senior Notes due 2031 and $800,000,000 of 7.375% Senior Notes due 2034.
The notes are senior unsecured obligations of the issuer and are guaranteed on a senior unsecured basis by Celanese Corporation and, initially, certain subsidiary guarantors. Interest will be paid semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2026.
Net proceeds from the offering, together with available cash, will be used to repay borrowings under Celanese’s five-year term loan credit agreement due 2027, to fund previously announced and upsized cash tender offers for approximately $1.2 billion of existing 6.665% notes due 2027 and 6.850% notes due 2028, and for general corporate purposes, which may include repaying other outstanding indebtedness.
Celanese Corporation reported that on December 16, 2025 it issued a press release detailing the early results and increase in size of its previously announced cash tender offers for two series of senior notes. The company is conducting cash tender offers to purchase up to an aggregate principal amount of $946,106,000 of its 6.665% Senior Notes due 2027 and up to $254,000,000 of its 6.850% Senior Notes due 2028. The filing mainly updates investors on the status and enlarged maximum size of these debt repurchase transactions.
Celanese Corp’s CEO and President, who also serves as a director, increased his personal stake in the company through a recent stock purchase. On 12/10/2025, he acquired 3,800 shares of Celanese common stock in an open market transaction coded as a purchase at a price of $41.5899 per share. Following this transaction, he beneficially owned 70,448.703 shares directly and an additional 597.0315 shares indirectly through a 401(k) plan. The form was filed for one reporting person, reflecting continued alignment of the senior executive’s holdings with Celanese’s equity.
Celanese Corp insider Chuck Kyrish, the company’s SVP & CFO, reported an equity transaction involving 5,000 shares of Celanese common stock on December 9, 2025, at a weighted average price of about $41.03 per share. After this activity, he beneficially owned 10,914.476 shares directly. The filing notes that the shares were executed in multiple trades within a price range from $40.885 to $41.112, and that detailed trade-by-trade information is available from the reporting person upon request.
Celanese Corporation announced that its subsidiary Celanese US Holdings LLC entered into an underwriting agreement for a new senior notes offering. The Issuer agreed to sell $600,000,000 aggregate principal amount of 7.000% Senior Notes due 2031 and $800,000,000 aggregate principal amount of 7.375% Senior Notes due 2034. The transaction is being conducted through a registered public offering under an existing shelf registration statement on Form S-3, using a prospectus, a related prospectus supplement dated December 2, 2025, and a free writing prospectus filed on December 3, 2025.